April 19, 2021
Stockholm, 19 April 2021 – Sanolium AB, parent of the Cambio Group operating entities, today announces that its Board of Directors has named Lars Andåker as interim Chief Executive Officer, effective immediately.
Mr Andåker succeeds Peter Gille, who has left the Company. Mr Andåker is a board member and has been with the business since 2012. He previously held the role of interim Chief Executive Officer for Cambio in 2014-2015. Mr Andåker is an experienced executive in the healthcare sector with prior roles including CEO of the Swedish Medical Association, County Council Director of Sörmland County and CEO of Swedish Patient Insurance.
Tomas Mora-Morrison, co-founder and Board Director of Cambio, said; “Cambio continues to perform strongly and deliver on its growth plan. We are now entering a new phase of growth that requires a different type of leadership to take Cambio to the next level. Peter has been an important part of our success story during his six years as CEO and he leaves with our best wishes.”
Peter Gille said; “It has been a privilege leading Cambio over the last six years. The company has almost tripled its revenues during that time to become the leading provider of EHR software solutions in Sweden. I am proud of these achievements and wish the company all future success. I will remain an investor in Cambio and look forward to following the development of the group.”
This information is information that Sanolium AB(publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 10:50 am CEST on 19 April 2021.
For further information, please contact:
Chief Marketing & Communication Officer
+46 7 0 79 34 83
Sanolium AB, parent of the Cambio Group operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.